Omega Healthcare Investors, Inc. $OHI Stock Position Reduced by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC cut its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 33,824 shares of the real estate investment trust’s stock after selling 629 shares during the period. Janney Montgomery Scott LLC’s holdings in Omega Healthcare Investors were worth $1,240,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Pallas Capital Advisors LLC boosted its position in Omega Healthcare Investors by 59.0% during the second quarter. Pallas Capital Advisors LLC now owns 11,915 shares of the real estate investment trust’s stock valued at $437,000 after purchasing an additional 4,420 shares during the last quarter. PFG Investments LLC boosted its position in Omega Healthcare Investors by 20.4% during the first quarter. PFG Investments LLC now owns 70,762 shares of the real estate investment trust’s stock valued at $2,695,000 after purchasing an additional 11,970 shares during the last quarter. Columbus Macro LLC acquired a new stake in Omega Healthcare Investors during the first quarter valued at $6,353,000. Asset Management One Co. Ltd. boosted its position in Omega Healthcare Investors by 5.0% during the first quarter. Asset Management One Co. Ltd. now owns 514,967 shares of the real estate investment trust’s stock valued at $19,610,000 after purchasing an additional 24,640 shares during the last quarter. Finally, Pinion Investment Advisors LLC boosted its position in Omega Healthcare Investors by 113.0% during the first quarter. Pinion Investment Advisors LLC now owns 38,190 shares of the real estate investment trust’s stock valued at $1,454,000 after purchasing an additional 20,262 shares during the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI opened at $39.83 on Monday. Omega Healthcare Investors, Inc. has a fifty-two week low of $35.04 and a fifty-two week high of $44.42. The business has a 50-day moving average of $41.57 and a two-hundred day moving average of $38.82. The stock has a market capitalization of $11.75 billion, a P/E ratio of 24.59, a P/E/G ratio of 1.86 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.32. The company had revenue of $235.60 million during the quarter, compared to analysts’ expectations of $248.49 million. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The business’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.71 earnings per share. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were paid a $0.67 dividend. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.7%. Omega Healthcare Investors’s payout ratio is presently 165.43%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on OHI. Cantor Fitzgerald began coverage on Omega Healthcare Investors in a research report on Wednesday, October 1st. They set an “overweight” rating and a $50.00 price objective for the company. Scotiabank lifted their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a “sector perform” rating in a research report on Thursday, August 28th. Wells Fargo & Company lifted their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. Mizuho boosted their price target on Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a “neutral” rating in a research report on Thursday, September 11th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of Omega Healthcare Investors in a research report on Wednesday, October 8th. Seven investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $44.44.

Insider Activity at Omega Healthcare Investors

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The stock was sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director directly owned 18,654 shares in the company, valued at approximately $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.50% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.